Taro Pharm Inds (TARO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 107,037 | 54,555 | 456,666 | 373,704 | 233,793 |
| Depreciation Amortization | 7,794 | 3,775 | 14,829 | 11,067 | 7,397 |
| Income taxes - deferred | 15,813 | 4,825 | 73,706 | -13,138 | -11,422 |
| Accounts receivable | -34,493 | -3,213 | 29,584 | 3,333 | 1,769 |
| Accounts payable and accrued liabilities | N/A | -3,377 | -2,290 | N/A | N/A |
| Other Working Capital | -47,818 | -8,704 | -80,086 | -17,329 | -30,573 |
| Other Operating Activity | 90,364 | 24,807 | -54,874 | -37,182 | -8,287 |
| Operating Cash Flow | $138,697 | $72,668 | $437,535 | $320,455 | $192,677 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -259,741 | -275,128 | 196,144 | 250,949 | 138,424 |
| PPE Investments | -11,809 | -4,557 | -27,247 | -26,377 | -19,238 |
| Purchase Of Investment | 75,528 | 46,940 | -286,617 | -301,616 | -281,792 |
| Purchase Sale Intangibles | -1,554 | -2,056 | -68 | 955 | -22 |
| Other Investing Activity | -1,554 | -2,056 | -58 | 955 | -22 |
| Investing Cash Flow | $-197,576 | $-234,801 | $-117,778 | $-76,089 | $-162,628 |
| Cash Flows From Financing Activities | |||||
| Common Stock Repurchased | -40,417 | -8,489 | -294,897 | -269,712 | -240,618 |
| Financing Cash Flow | $-40,417 | $-8,489 | $-294,897 | $-269,712 | $-240,618 |
| Exchange Rate Effect | 2,218 | 936 | -1,218 | -1,765 | -550 |
| Beginning Cash Position | 600,399 | 600,399 | 576,757 | 576,757 | 576,757 |
| End Cash Position | 503,321 | 430,713 | 600,399 | 549,646 | 365,638 |
| Net Cash Flow | $-97,078 | $-169,686 | $23,642 | $-27,111 | $-211,119 |
| Free Cash Flow | |||||
| Operating Cash Flow | 138,697 | 72,668 | 437,535 | 320,455 | 192,677 |
| Capital Expenditure | -11,809 | -4,557 | -35,755 | -26,377 | -19,238 |
| Free Cash Flow | 126,888 | 68,111 | 401,780 | 294,078 | 173,439 |